HealthDay - FRIDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved the cancer drug Avastin for women with advanced breast cancer, going against the recommendation of its own advisory panel.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.